No Data
No Data
Stable, with the decline in US stocks as a burden [Emerging Markets Individual Stock Global Strategy]
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show strong performance. In the U.S. stock market yesterday, on the 18th, the Dow Inc. fell by 260.32 points (-0.62%) to 41,581.31, marking a decline for the first time in three days. Profit-taking sales, particularly in high-tech sectors, and adjustment selling ahead of the Federal Open Market Committee (FOMC) announcement weighed on stock prices, while reports stating that Russia agreed to limit attacks on Ukraine's infrastructure in the U.S.-Russia summit served as a supporting factor for stock prices.
CINC, Good Patch and others.
The share buyback by CINCF has a maximum of 0.52 million shares (15.42% of the total shares issued) and will be purchased on the 19th through ToSTNeT-3. DWTI has completed the administration of the treatment for corneal endothelial degeneration, "K-321", in the Global Phase III clinical trial. KAIOM has signed a business partnership agreement with SRD, which handles clinical development and regulatory support for Pharmaceuticals and Medical Devices.
Japan skiing, Oncolis Bio and others.
A capital and business alliance agreement has been concluded with HUMEDIT, which handles various tests (NIPT/NI-PGS/PCR) such as the issuance of new stocks through third-party allocation (0.07 million3099 shares) and the disposal of treasury shares (0.18 million201 shares). <4584> Kids Bio had a large exercise of subscription rights (with price adjustment clauses) from the 24th, with the number of shares to be delivered starting from the 5th being 0.9 million shares. <4588> Oncolys Bio is conducting clinical research on the next-generation tumor lytic virus OBP-702.
Oncolys BioPharma: Earnings Conference materials
Oncolys BioPharma Reports 2024 Financial Results Highlighting Improved Equity Ratio
Oncolys BioPharma: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)